Sirolimus for Pediatric Cervicofacial Lymphatic Malformation: A Systematic Review and Meta‐Analysis
The Laryngoscope · 2024-05 · 134 (5) · 2038-2047
DOI: 10.1002/lary.31091 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Laryngoscope, online erschienen am 09.10.2023. Verfasst von Yasmine Kamhieh und 5 weiteren Autor:innen. Beteiligte Einrichtung: ENT Department Noah's Ark Children's Hospital, Cardiff, UK. Hauptthemen laut MEDLINE: Lymphatic Abnormalities, Sirolimus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
This study is a systematic review and meta‐analysis of the efficacy and safety of sirolimus in the management of pediatric cervicofacial lymphatic malformations (LMs). Data Sources EMBASE, Medline, Scopus, and Cochrane databases were searched, along with the reference list of all included articles. Review Methods The study protocol was registered with PROSPERO and a systematic literature search strategy was designed and conducted with the aid of a medical librarian. All studies including case reports were included, with pooled analysis of raw data. A meta‐analysis was conducted of magnetic resonance imaging (MRI), clinical, and airway outcomes.
Results
Thirteen case series and five individual case reports were included. Meta‐analysis showed 78% (95% CI 57%–94%) of 62 patients had a reduction in LM volume, on MRI criteria, by 20% or more, and 32% (95% CI 11%–57%) had a reduction of 50% or more. Further meta‐analysis showed 97% (95% CI 88%–100%) of 78 patients reported some clinical improvement on sirolimus. Sirolimus may be of particular value in management of airway LMs; out of 27 tracheostomy‐dependent patients, meta‐analysis showed 33% (95% CI 1%–78%) were decannulated after starting sirolimus. Individual patient meta‐analysis on 24 individuals showed a statistically significant better response to sirolimus when initiated under the age of 2 years.
Conclusion
This review and meta‐analysis support the efficacy of sirolimus in pediatric LMs of the head, neck, and airway. A large multi‐center trial is needed to further explore its role and limitations. Laryngoscope , 134:2038–2047, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ENT Department Noah's Ark Children's Hospital, Cardiff, UK.
- Department of Statistics, University College of London, London, UK.
- Department of Mathematical Sciences, University of Bath, Bath, BA2 7AY, UK.
- Cardiff University, Cardiff, CF10 3AT, UK.
ORCID-Profile: Yasmine Kamhieh
Zitieren
APA
Kamhieh, Y., Mitra, R., Burnett, T., Jones, H., Roblin, G., & Hall, A. (2024). Sirolimus for Pediatric Cervicofacial Lymphatic Malformation: A Systematic Review and Meta‐Analysis. The Laryngoscope, 134(5), 2038-2047. https://doi.org/10.1002/lary.31091
Vancouver
Kamhieh Y, Mitra R, Burnett T, Jones H, Roblin G, Hall A. Sirolimus for Pediatric Cervicofacial Lymphatic Malformation: A Systematic Review and Meta‐Analysis. The Laryngoscope. 2024;134(5):2038-2047. doi:10.1002/lary.31091
BibTeX
@article{Kamhieh2024,
author = {Kamhieh, Yasmine and Mitra, Robin and Burnett, Thomas and Jones, Hugh and Roblin, Graham and Hall, Andrew},
title = {Sirolimus for Pediatric Cervicofacial Lymphatic Malformation: A Systematic Review and Meta‐Analysis},
journal = {The Laryngoscope},
year = {2024},
volume = {134},
number = {5},
pages = {2038--2047},
doi = {10.1002/lary.31091}
}
EUVIMED